Literature DB >> 19303161

Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins.

Janne Makkonen1, Kirsi H Pietiläinen, Aila Rissanen, Jaakko Kaprio, Hannele Yki-Järvinen.   

Abstract

BACKGROUND/AIMS: This study aimed to determine the heritability of serum alanine aminotransferase (S-ALT) and fasting serum insulin (fS-insulin) concentration as well as determine the association of these measures with liver fat content in young adult monozygotic (MZ) and dizygotic (DZ) twins.
METHODS: Three hundred and thirteen individual twins were recruited from a population-based cohort (n = 4929). The study subjects represented a wide range of body mass indexes (BMI), were free of any diseases or regular medications and had an intake of less than two drinks of alcohol/day. To verify that S-ALT is a marker of liver fat, it was measured by proton magnetic resonance spectroscopy ((1)H MRS) in 66 subjects. Heritability estimations were performed using BMI- and gender-adjusted values.
RESULTS: Intra-pair correlations were significantly higher in the MZ twins than the DZ twins for both S-ALT (0.65 for MZ and 0.04 for DZ) and fS-insulin (0.58 and 0.34, respectively). Heritability of S-ALT was 55% and that of fS-insulin 61%. In the 66 subjects S-ALT (r = 0.70 for women and r = 0.50 for men, p < or = 0.01 for both) and fS-insulin (r = 0.58 and r = 0.59, respectively, p < or = 0.01 for both) concentrations correlated significantly with liver fat content.
CONCLUSIONS: These twin data suggest that approximately 60% of the variation in S-ALT, a marker of liver fat content, is genetically determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303161     DOI: 10.1016/j.jhep.2008.12.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

Review 2.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

3.  Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.

Authors:  Michelle T Long; Ellen B Gurary; Joseph M Massaro; Jiantao Ma; Udo Hoffmann; Raymond T Chung; Emelia J Benjamin; Rohit Loomba
Journal:  Liver Int       Date:  2018-09-25       Impact factor: 5.828

Review 4.  Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.

Authors:  Rotonya M Carr; Amanke Oranu; Vandana Khungar
Journal:  Gastroenterol Clin North Am       Date:  2016-10-13       Impact factor: 3.806

5.  The genetic architecture of liver enzyme levels: GGT, ALT and AST.

Authors:  Jenny H D A van Beek; Marleen H M de Moor; Eco J C de Geus; Gitta H Lubke; Jacqueline M Vink; Gonneke Willemsen; Dorret I Boomsma
Journal:  Behav Genet       Date:  2013-04-12       Impact factor: 2.805

6.  The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study.

Authors:  Mary F Feitosa; Mary K Wojczynski; Kari E North; Qunyuan Zhang; Michael A Province; Jeffrey J Carr; Ingrid B Borecki
Journal:  Atherosclerosis       Date:  2013-02-18       Impact factor: 5.162

Review 7.  Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.

Authors:  Silvia Sookoian; Carlos J Pirola; Luca Valenti; Nicholas O Davidson
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

Review 8.  The genetics of NAFLD.

Authors:  Quentin M Anstee; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 9.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

10.  Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents.

Authors:  Valerio Nobili; Daniela Liccardo; Giorgio Bedogni; Guglielmo Salvatori; Daniela Gnani; Iliana Bersani; Anna Alisi; Luca Valenti; Massimiliano Raponi
Journal:  Genes Nutr       Date:  2014-03-14       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.